Literature DB >> 19472955

Pseudomeniscal synovial impingement after unicondylar knee arthroplasty.

Kwang Am Jung1, Su Chan Lee, Seung Hyun Hwang.   

Abstract

Unicondylar knee arthroplasty (UKA) is a well-established treatment option for unicompartmental knee arthrosis. Although UKA achieves high success rates, surgeons should be aware of many potential sources of persistent postoperative pain. Common causes include septic or aseptic loosening, a loose body, implant failure, and chronic regional pain syndrome. Tibial plateau stress fracture, meniscus rupture, and cement extrusion have also been reported as infrequent causes of persistent pain. We encountered 2 patients in whom persistent pain after UKA was attributed to synovial impingement mimicking a meniscus tear, and we refer to this as pseudomeniscal synovial impingement. This article presents the clinical histories and histologic findings of 2 patients fitted with a mobile-bearing UKA system and a fixed-bearing UKA system, respectively. These patients were successfully treated by arthroscopic excision.

Entities:  

Mesh:

Year:  2009        PMID: 19472955     DOI: 10.3928/01477447-20090501-05

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

Review 1.  Causes of revision following Oxford phase 3 unicompartmental knee arthroplasty.

Authors:  Seung-Ju Kim; Ricardo Postigo; Sowon Koo; Jong Hun Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-01       Impact factor: 4.342

2.  Exploring the relationship between bearing extrusion and postoperative persistent pain in Oxford unicompartmental knee arthroplasty: A trajectory measurement study.

Authors:  Pengfei Wen; Qidong Zhang; Xiaowei Sun; Binfei Zhang; Tao Ma; Yumin Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-29

3.  Clinical outcomes of patients with residual medial osteophytes following mobile bearing unicompartmental knee arthroplasty.

Authors:  Boonchana Pongcharoen; Nuttawut Chanalithichai
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.